ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2018

Dec 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2018-12-18

Reporting Person: Ferrari Mauro (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-18	Common Stock	A	3459	$0.00	Acquired	16227	Direct

Footnotes

F1: This balance reflects the cancellation of 50,000 restricted stock units that were previously granted and reported on January 1, 2017. Dr. Ferrari's employer limits the amount of compensation he can take, and as such, these restricted stock units were subsequently cancelled.